This document specifies good clinical practice (GCP) for the design, conduct, recording and reporting of clinical investigations carried out in human subjects to assess the clinical performance or effectiveness and safety of medical devices.
For post-market clinical investigations, the principles set forth in this document are intended to be followed as far as relevant, considering the nature of the clinical investigation (see Annex I).
This document specifies the general requirements intended to
Other standards or national requirements can also apply to the investigational device(s) under consideration or the clinical investigation(s).
NOTE For Software as a Medical Device (SaMD), where appropriate, demonstration of the analytical validity (the SaMDs output is accurate for a given input), the scientific validity (the SaMDs output is associated to the intended clinical condition/physiological state), and clinical performance (the SaMDs output yields a clinically meaningful association to the target use) of the SaMD, the requirements of this document apply as far as relevant (see Reference [5]). Justifications for exemptions from this document can consider the uniqueness of indirect contact between subjects and the SaMD.
This document does not apply to in vitro diagnostic medical devices. However, there can be situations, dependent on the device and national or regional requirements, where users of this document can consider whether either specific sections or requirements of this document, or both, can be applicable.
| SDO | ISO: International Organization for Standardization |
| Document Number | ISO 14155 |
| Publication Date | Not Available |
| Language | en - English |
| Page Count | 94 |
| Revision Level | |
| Supercedes | |
| Committee | ISO/TC 194 |
Failed to load document history.
| Publish Date | Document Id | Type | View |
|---|